Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

BRCA2 anticorps (AA 200-500)

Cet anticorps Souris Monoclonal détecte spécifiquement BRCA2 dans IHC. Il présente une réactivité avec des échantillons de Humain.
N° du produit ABIN7864856
687,58 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour BRCA2 anticorps (AA 200-500) (ABIN7864856)

Antigène

Voir toutes BRCA2 Anticorps
BRCA2 (Breast Cancer 2, Early Onset (BRCA2))

Reactivité

  • 45
  • 18
  • 13
  • 4
  • 1
Humain

Hôte

  • 38
  • 14
Souris

Clonalité

  • 37
  • 14
  • 1
Monoclonal

Conjugué

  • 39
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp BRCA2 est non-conjugé

Application

  • 31
  • 17
  • 13
  • 9
  • 7
  • 5
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)

Clone

BRCA2-2158
  • Épitope

    • 12
    • 6
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 200-500

    Fonction

    BRCA2 (Breast Marker) Antibody

    Specificité

    In 1990, a breast cancer susceptibility gene designated BRCA1 was localized to chromosome 17q. Mutations within this gene are believed to account for approximately 45 % of families with high incidence of breast cancer and at least 80 % of families with increased incidence of both early-onset breast cancer and ovarian cancer. A second breast cancer susceptibility gene, BRCA2 (breast cancer 2, early onset), located on chromosome 13q13.1, also confers a high incidence of breast cancer but, unlike BRCA1, does not confer a substantially elevated risk of ovarian cancer. Both BRCA1 and BRCA2 play a role in the maintainance of genome stability, particularly in the homologous recombination pathway for double-strand DNA repair. BRCA2 is regarded as a tumor suppressor gene, tumors with BRCA2 mutations exhibit loss of heterozygosity (LOH) of the wildtype allele. The protein encoded by the BRCA2 gene contains multiple copies of a 70 amino acid motif called the BRC motif. These motifs effect binding to the Rad51 recombinase, which operates in DNA repair.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant fragment (around aa 200-500) of human BRCA2 protein (exact sequence is proprietary)

    Isotype

    IgG1, kappa
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C.Antibody is stable for 24 months. Non-hazardous. No MSDS required.
  • Antigène

    BRCA2 (Breast Cancer 2, Early Onset (BRCA2))

    Autre désignation

    BRCA2

    Sujet

    BRCA1/BRCA2 containing complex subunit 2, BRCA2, DNA repair associated, BRCC2, Breast and ovarian cancer susceptibility gene early onset, breast and ovarian cancer susceptibility protein 2, Breast cancer 2 early onset, Breast Cancer 2 tumor suppressor, BROVCA2, FACD, FAD1, FANCB, FANCD, FANCD1, Fanconi anemia complementation group D1, GLM3, mutant BRCA2, PNCA2, XRCC11

    A431 or HeLa cells. Human breast|lung|ovary or spleen.|thymus

    Poids moléculaire

    390kDa

    ID gène

    675, 34012

    Pathways

    Réparation de l'ADN, M Phase, Maintenance of Protein Location
Vous êtes ici:
Chat with us!